Podcasts about msci

Shares of capital market company MSCI and credit rating agency Equifax both posted double digit declines after posting earnings that were…ok? Matt, Lou, and Tyler dive into what went right and wrong in the most recent earnings and what to make of the two stocks today. Plus, what to make of the oil markets using Halliburton's earnings results and what is the best banking ETF today? Have a question? Email us; podcasts@fool.com Want to take the next step in your investing journey? Explore Motley Fool's Epic for our portfolio-centered investing experience, premium research, tools, and guidance: fool.com/epic fool.com/epic Tyler Crowe, Matt Frankel, and Lou Whiteman discuss: - Equifax & MSCI earnings and stock reactions - AI costs eating into profits - Halliburton's comments on the oil market - Mailbag: Best Banking ETF to buy now? Companies discussed: EFX, MSCI, MS, HAL, XLF, VFH, BRK, V, MA, JPM, KBE, KBWB Host: Tyler Crowe Guests: Matt Frankel, Lou Whiteman Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Business and finance news from the Asia-Pacific. Oil climbed to the highest level in more than a month and bonds fell as US and Iranian attacks escalated, renewing inflation concerns. Stocks stabilized after a technology-led selloff rattled markets last week. Treasury 10-year futures slipped 7/32, with trading in the cash market shut during Asian hours Monday because of a holiday in Japan. Government bonds in Australia and New Zealand also declined on concern that higher oil prices will stoke inflation. Equities were mixed. Nasdaq 100 futures rose 0.2% after Friday’s selloff, as Moonshot AI told investors it plans to go public within six months after its latest model challenged perceptions of US leadership in artificial intelligence. MSCI’s Asia Pacific equity index was little changed, while South Korea’s Kospi index fell 2.8% as traders returned following a holiday on Friday. For a look at the markets, Bloomberg TV Host Avril Hong spoke to Homin Lee, Senior Macro Strategist at Lombard Odier. Brent rose as much as 3.8% to $91.42 a barrel, the highest level since June, with back-and-forth strikes that have expanded beyond military targets. For an outlook of how the oil story is impacting the Asia-Pacific, Bloomberg TV Host Paul ALlen spoke to Illiana Jain, International Ecnomist at Westpac Banking Corporation.See omnystudio.com/listener for privacy information.

Heute ist Freitag – und das bedeutet: Babotag! Die Investmentbabos Michael und Endrit haben heute wieder ein spannendes Thema für euch. Angesichts der Entwicklungen an den Kryptomärkten, insbesondere in den vergangenen zwölf Monaten, haben sie sich einen besonderen Gast eingeladen. Gemeinsam mit Ronald Richter von Bitwise – einem der führenden Anbieter im Bereich Krypto-Assets – sprechen die Babos nicht nur über die Entwicklung der Kryptomärkte, sondern auch über Produkte, die Krypto-Assets abbilden. Im Fokus stehen dabei Basket-Lösungen in Zusammenarbeit mit MSCI sowie die entsprechenden ETPs. Außerdem geht es um Themen wie Kosten, Rebalancing, die Positionierung innerhalb der Indizes und die Frage, wie diese Produkte aktuell vom Markt angenommen werden. Wenn ihr mehr darüber erfahren möchtet, dann schaltet unbedingt ein! Diese Folge ist ein wichtiger Baustein, und wir freuen uns schon jetzt auf Teil 2, in dem wir noch tiefer auf einzelne Krypto-Assets & Coins sowie die allgemeine Marktlage eingehen werden. Viel Spaß, ein schönes Wochenende und bis nächste Woche bei „Babos sprechen Börse“. Liebe Grüße Michael Duarte & Endrit Cela - Hier geht es zur Investmentbabo-Webseite: https://www.investmentbabo.com - Folgt die Investmentbabos auf Instagram: https://www.instagram.com/investmentbabo DISCLAIMER: Der Inhalt dieses Podcasts dient ausschließlich der allgemeinen Information. Diese Informationen können und sollen eine individuelle Beratung durch hierfür qualifizierte Personen nicht ersetzen. Die Informationen in Bezug auf die von der Clartan Associés und AMF Capital AG verwalteten Sondervermögen stellen keine Anlageberatung und keine Kaufempfehlung dar.

Escalating military tensions between the US and Iran have renewed concerns over energy prices, while volatility in AI-linked technology stocks, particularly in East Asia continues to rise. S&P Dow Jones follows MSCI in potentially downgrading the Indonesia market to ‘frontier’ status, while traders remain alert for Japan’s yen intervention. In this episode of Market Focus Weekly, JP Morgan Asset Management’s Raisah Rasid unpacks the market moves for the week – revealing the direction of travel for oil prices, how the AI story is evolving, and why South Korea’s tech sell off is not an exit signal. Highlights: 01:24  Oil unlikely to return to pre Iran war levels soon 04:33 AI story is not broken, but evolving 06:37 Reducing concentration risk in tech heavy markets 10:11 Active stock selection crucial in Indonesia market 13:35 Yen intervention provides short-term relief --- Send us your questions, thoughts, story ideas, and feedback to btpodcasts@sph.com.sg. --- Hosted by: Claressa Monteiro (claremb@sph.com.sg) Written by: Nicole Teo With Raisah Rasid, global market strategist, JP Morgan Asset Management Edited by: Nicole Teo & Claressa Monteiro Produced by: Nicole Teo & Chai Pei Chieh A podcast by BT Podcasts, The Business Times, SPH Media --- Follow Market Focus Weekly podcasts every Friday: Channel: bt.sg/btmktfocus Amazon: bt.sg/mfam Apple Podcasts: bt.sg/mfap Spotify: bt.sg/mfsp YouTube Music: bt.sg/mfyt Website: bt.sg/mktfocus Do note: This podcast is meant to provide general information only. SPH Media accepts no liability for loss arising from any reliance on the podcast or use of third party’s products and services. Please consult professional advisors for independent advice. Discover more BT podcast series: BT Money Hacks at: bt.sg/btmoneyhacks BT Correspondents at: bt.sg/btcobt BT Podcasts at: bt.sg/podcasts BT Lens On: bt.sg/btlensonSee omnystudio.com/listener for privacy information.

Interview with Dan-Mircea Mirea, MSci, author of The Reinforcement Effect of Social Media Likes in Depression. Hosted by John Torous, MD. Related Content: The Reinforcement Effect of Social Media Likes in Depression Do Likes Reinforce Depression?

現在要在南韓外匯市場交易韓元，不用再等當地白天的交易時段了。南韓從6日起開放24小時全天候交易韓元，結束了實施將近30年的交易時段限制。當局表示這是為了提升外資交易便利性，吸引更多國際資金流入，並且讓南韓更符合「MSCI」已開發市場資格。不過全天候交易也意味著，歐美市場的影響會更即時反映在韓元上，需要注意匯率是否會劇烈波動。加入會員，支持節目： https://globalhashtagnews.firstory.io/join留言告訴我你對這一集的想法： https://open.firstory.me/user/cku2d315gwbbo0947nezjmg86/commentsYT收看《寰宇全視界》

Volatility in AI-linked technology stocks, globally and across Asia, continues to rise. Indonesia faces uncertainty over a possible MSCI downgrade, and traders remain on high alert for Japan’s yen intervention. In this episode of Market Focus Weekly, Standard Chartered Bank’s Yap Fook Hien unpacks the market moves for the week – revealing their bullish views for South Korean and Japanese equities, why strong earnings continue to buoy risks of an AI bubble, and why oil and gold prices still have further upside. Highlights: 01:10 Valuations for Korean stocks still ‘low’ 03:21 Yen intervention risks 10:05 Why AI is not in a bubble 14:52 Gold remains an important diversifier --- Send us your questions, thoughts, story ideas, and feedback to btpodcasts@sph.com.sg. --- Written and hosted by: Howie Lim (howielim@sph.com.sg) With Yap Fook Hien, senior investment strategist, Standard Chartered Bank Edited by: Howie Lim & Claressa Monteiro Produced by: Howie Lim & Chai Pei Chieh A podcast by BT Podcasts, The Business Times, SPH Media --- Follow Market Focus Weekly podcasts every Friday: Channel: bt.sg/btmktfocus Amazon: bt.sg/mfam Apple Podcasts: bt.sg/mfap Spotify: bt.sg/mfsp YouTube Music: bt.sg/mfyt Website: bt.sg/mktfocus Do note: This podcast is meant to provide general information only. SPH Media accepts no liability for loss arising from any reliance on the podcast or use of third party’s products and services. Please consult professional advisors for independent advice. Discover more BT podcast series: BT Money Hacks at: bt.sg/btmoneyhacks BT Correspondents at: bt.sg/btcobt BT Podcasts at: bt.sg/podcasts BT Lens On: bt.sg/btlensonSee omnystudio.com/listener for privacy information.

Hay un aspecto de la salida a bolsa de SpaceX poco comentado: su pésima calificación en los criterios ESG (medioambiental, social y gobernanza). MSCI ha otorgado a SpaceX una calificación de CCC, un suspenso en toda regla. Lee el artículo completo en r4.com.

Unser Partner Scalable Capital ist der einzige Broker, den deine Familie zum Traden braucht. Bei Scalable Capital gibt's nämlich auch Kinderdepots. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Micron wächst krass. Rheinmetall verliert Fregatten. TKMS profitiert. Wendy's explodiert dank Reddit. SK Hynix plant Giga-IPO. Cerebras enttäuscht trotz starker Prognose. Ölpreis fällt. Gold auch. MSCI lässt Indonesien und Südkorea da wo sie sind. Strategy (WKN: 722713) verliert trotz stabilem Bitcoin. Ihre Vorzugsaktie fällt unter den Zielkurs von 100 $. Michael Saylor hat das Finanzinstrument mit ChatGPT entwickelt. Vertrauen in das Geschäftsmodell sinkt. Muss Bitcoin ins Altersvorsorge-Portfolio? Und bedrohen Quantencomputer alles? Diesen Podcast vom 25.06.2026, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung. Learn more about your ad choices. Visit megaphone.fm/adchoices

This month's Mailbag ranges from Washington, D.C. to Germany, from the SEC to the moon, and from individual stock ownership to the deeper question of what freedom is actually for. Along the way, fellow Fools write in about transparency, curiosity, market caps, parenting, AI, adding to winning investments, and what can happen when decades of patient investing quietly compound into opportunities to help others. As always, the best part of the Mailbag is you.Host: David GardnerProducer: Bart ShannonCompanies Mentioned: HAS, ISRG, JEPI, KO, MAT, MSCI, NKE, NVDA Learn more about your ad choices. Visit megaphone.fm/adchoices

Introducing Market Open: a new weekly show from The Modern Investor. Each week, Finimize analysts Reda Farran and Russell Burns chew over the biggest stories in markets, what they mean for investors, and what they're watching in the week ahead.In todays episode....Why AI is increasingly driving every corner of financial marketsSpaceX's latest AI deals and what they mean for the companySouth Korea's push for MSCI developed-market statusThe outlook for inflation, rates, and the global economyTry Finimize Pro

오늘의 경제 뉴스 - 코스피 '검은 화요일'… MSCI 선진국지수 편입 불발

En el capítulo 1.142 de este miércoles, 24 de junio, @franaldaya les comenta que el dólar mayorista se despertó sobre el final del semestre, qué decidió MSCI para las acciones argentinas, y la sorpresa del crecimiento económico argentino en el primer trimestre aun con más desempleo y salarios por detrás de la inflación. Además, Juan Pablo Álvarez en La Fija, con el CEO y fundador de Ualá, Pierpaolo Barbieri.

Another wave of panic has hit the crypto market. Bitcoin is falling, Ethereum is bleeding, and altcoins are rapidly losing momentum as traders rush to exit leveraged positions. More than $660 million has already been wiped out in liquidations, turning what began as a pullback into a full-scale risk-off event as the A.I. tech bubble shows signs of weakness. ~This Episode is Sponsored by OKX~ Trade RLUSD/XRP on OKX + claim the new user offer! Deposit and trade $200 to unlock $100 ➜ https://bit.ly/OKXRP Use code: paulbarron *Terms Apply* 00:00 intro 00:05 Sponsor: OKX 01:00 Markets Crash! 01:59 Morgan Stanley on Porfolio Management 02:23 Peak Concentration 03:17 Mag 7 Cap-Ex Spending & Issuance 04:04 Corporate Bonds 04:05 Gareth Soloway: Market Breakdown? 05:20 SpaceX downgraded by MSCI & Softbank 07:32 Micron earnings tomorrow 08:37 Bitcoin vs Gold & S&P500 09:20 TradFi gives up on Bitcoin 10:06 A.I. Rotation continues 10:39 South Korea fails to enter developed markets 11:50 Samsung stock growth 12:36 Private Credit bubble 13:13 Robinhood vs Coinbase 13:55 Diversify into Stocks and Crypto 14:54 JD Vance on Iran Deal 15:05 Iran denies White House facts 15:36 Oil price limbo 16:16 CLARITY Act lowest odds since January 17:19 Stay Tuned 17:34 outro #Crypto #Bitcoin #AI ~Everything Crashing!?

De Dekkingsgraad is de tweewekelijkse nieuwspodcast van Pensioen Pro. Daarin lichten redacteuren van Pensioen Pro in ongeveer een half uur het belangrijkste pensioennieuws van de afgelopen periode toe. In deze aflevering: Het bedrag ineens is eindelijk door de Eerste Kamer. Deelnemers van een pensioenfonds kunnen een bedrag opnemen vanaf 2029. Hoe de stemming verliep en waarom invoering nog 2,5 jaar duurt, vertelt redacteur Olaf Boschman. De hele transitiegroep van 1 juli 2026 heeft de invaarbeschikking binnen. Om welke fondsen het gaat en of ze nog aanpassingen hebben moeten doen in de laatste fase, vertelt redacteur Rien Meijer. In de opname is het ondernemingspensioenfonds van Vopak onbenoemd gebleven, dat ook op 1 juli invaart én een invaarbeschikking van DNB binnen heeft.>Klik hier voor het geüpdatet transitieoverzicht En de beursgang van ruimtevaartbedrijf SpaceX houdt pensioenfondsen bezig. SpaceX verschijnt al snel in de indices van indexaanbieders MSCI en FTSE. Of dat ook betekent dat pensioenfondsen massaal gaan beleggen in SpaceX, vertelt redacteur Sameer van Alfen. Presentatie: Ilse AkkermansSee omnystudio.com/listener for privacy information.

W Polsce żyjemy pasywną rewolucją, lokalną hossą i rozwojem ETF-ów na podstawowe indeksy, podczas gdy rynek tych instrumentów w krajach Europy Zachodniej przechodzi ciekawą transformację. Nowe ETF-y powstają bardzo szybko, większość z nich jest aktywnie zarządzana, coraz więcej mówi się o ich tokenizacji, a pojawia się nawet ETF zrobiony przez... dom maklerski!W która stronę zmierzamy na europejskim rynku? Na to i inne pytania odpowiada Artur Wiśniewski z bloga Stockbroker.plO co jeszcze pytałem Artura?jak ocenia aktualny rynek uług ETF?na ile pasywna rewolucja w Polsce "wyszla z bańki"?jakie nowe produkty dominują na rozwiniętych rynkach? co sądzi o tokenizacji ETF-ów i czy to ma racjonalne uzasadnienie?a co gdyby XTB zrobiło swój ETF?czemu rośnie popularność ETF-ów obligacyjnych w Europie? jakie są pułapki inwestowania w ETF-y?jak widzi przyszłość OKI?Gdzie znajdziecie gościa podcastu?Stockbroker.plPasywnarewolucja.plNewsletter podcastu: https://niczadarmo.substack.com/Zajrzyj do księgarni: https://finansoweksiazki.pl/  

There's an uptick in ship crossings through the Strait of Hormuz, says Charles Schwab's Kevin Gordon, believing it offers a small reprieve for the energy trade. He sees Micron's (MU) earnings and this week's inflation prints as prominent catalysts to move markets. Michelle Gibley sticks with the AI trade by explaining what the MSCI reclassification means for global stocks, including South Korean tech giants Samsung and SK Hynix. ======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

En el capítulo 1.140 de este lunes, 22 de junio, @franaldaya les comenta que la revisión de accesibilidad de MSCI fue un balde de agua frío para las acciones argentinas, que la última encuesta de gestores de Bank of America muestra a los inversores recortando Brasil y eligiendo a Colombia y la Argentina, y que un informe de Bloomberg Intelligence revive los paralelos con las crisis de 1929 y 2008. Además, Mariano Espina en Recintos del Poder.

Fundusze ETF zmieniają rynek, a coraz więcej aktywnie zarządzanych funduszy inwestycyjnych analizuje wpływ zmian w indeksach na wyceny spółek, a nawet całych rynków. O tym, jak w praktyce to robić i jakie ważne wydarzenia mogą w najbliższym czasie dotyczyć Polski, rozmawiamy w najnowszym odcinku podcastu z Pawłem Wieprzowskim z PKO TFI.Debiut SpaceX na giełdzie w USA ma sporo wspólnego z debiutem Allegro na GPW. Obie spółki w przyspieszonym trybie trafiły do indeksów, co wywołało popyt na akcje. O innych przykładach tego rodzaju zmian, charakterystyce rynków rozwiniętych i rozwijających się oraz o spektakularnych przypadkach reklasyfikacji rozmawiamy w najnowszym odcinku podcastu.Zapraszamy do odcinka o inwestowaniu z perspektywy indeksów, zmian wag, przeważania i niedoważania, którego gościem jest Paweł Wieprzowski, zarządzający w PKO TFI.W tym podcaście:02:00 Czym różni się praca analityka od pracy zarządzającego funduszami?05:00 Dlaczego indeksy i zmiany składów indeksów mają coraz większe znaczenie?07:30 Historie Budimeksu i Pepco jako przykłady wpływu zmian składu indeksów na kursy akcji10:00 Debiut Allegro12:00 Debiut SpaceX15:30 Czy składy indeksów i zmiany wag wpływają na całe kraje i gospodarki?19:00 Reklasyfikacje krajów i ich wpływ na rynek oraz gospodarkę23:00 Jak wygląda proces reklasyfikacji rynku?25:30 Indeksy MSCI muszą być inwestowalne27:30 Ważne zmiany w reklasyfikacji rynków, które mogą wpłynąć na polską giełdę30:10 Z czego wynika wzrost zainteresowania inwestorów zagranicznych Polską?34:30 Czy Polska może wejść do developed market w nomenklaturze MSCI?36:00 Co mogłoby to oznaczać dla GPW w praktyce?Zawarte w materiale dane, opracowania, informacje, analizy zostały przygotowane wyłącznie w celach informacyjnych, są tylko i wyłącznie subiektywnymi opiniami autorów i nie są rekomendacjami zawarcia transakcji w rozumieniu § 3 Rozporządzenia Ministra Finansów z dnia 19 października 2005 r. w sprawie informacji stanowiących rekomendacje dotyczące instrumentów finansowych, lub ich emitentów lub wystawców m. in. nie opierają się na żadnej metodzie wyceny walorów oraz nie określają ryzyka inwestycyjnego, nie zawierają bezpośrednich zaleceń podjęcia określonych działań inwestycyjnych, przez co nie mogą być traktowane jako doradztwo finansowe, prawne, podatkowe czy też jakiekolwiek inne doradztwo inwestycyjne w rozumieniu art.76 ustawy z dnia 29 lipca 2005r. o obrocie instrumentami finansowymi. Zgodnie z powyższym autorzy nie ponoszą jakiejkolwiek odpowiedzialności za decyzje inwestycyjne podejmowane na podstawie treści zawartych w artykule albowiem nie jest intencją Usługodawcy dokonywanie bezpośrednich porad inwestycyjnych.

Fri, 19 Jun 2026 09:35:00 +0000 https://jungeanleger.podigee.io/3190-wiener-borse-party-1181-atx-unverandert-at-s-mit-der-doppelten-600-und-msci-vs-stoxx-palfinger-nach-auftrag-gesucht f4496e5d3887333666e240804813c350 Die Wiener Börse Party ist ein Podcastprojekt für Audio-CD.at von Christian Drastil Comm.. Unter dem Motto „Market & Me“ berichtet Christian Drastil über das Tagesgeschehen an der Wiener Börse. Inhalte der Folge #1181: - ATX unverändert - AT&S mit der doppelten 600 und MSCI vs. Stoxx - Palfinger gesucht - PIR-News: Höhere Kursziele für AT&S und DO & CO, Aufträge für Strabag und Palfinger - Markus Tritthart läutet die Opening Bell für Freitag. Der Geschäftsführer der Raiffeisen Bausparkasse bietet mit seinem klassischen und immer modernen Bausparen einen Basisbaustein des wichtigen Auf-die-Seite-Legens - Börse Frankfurt mit dem DAX weiter über 25.000 - mithören in der U-Bahn - mehr dazu im Podcast bzw. in einem Trial unter https://www.boerse-express.com/suche?search=drastil Links:  - WM Songs: http://www.audio-cd.at/music - Börsepeople Harald Suekar: http://www.audio-cd.at/people - Fanboy-Fundraising: http://www.christian-drastil.com - Stockpicking Österreich: https://www.wikifolio.com/de/at/w/wfdrastil1? - Austria 30 Private IR: https://www.wikifolio.com/de/at/w/wf00atat30 ATX aktuell: https://www.wienerborse.at/indizes/aktuelle-indexwerte/preise-mitglieder/??ISIN=AT0000999982&ID_NOTATION=92866&cHash=49b7ab71e783b5ef2864ad3c8a5cdbc1 Die täglichen Folgen der Wiener Börse Party (Co-verantwortlich Script: Christine Petzwinkler) sind 2026 präsentiert von der Deutsche Börse Xetra https://live.deutsche-boerse.com/xetraplus . Infos zum Jingle: https://audio-cd.at/page/podcast/7326 Risikohinweis: Die hier veröffentlichten Gedanken sind weder als Empfehlung noch als ein Angebot oder eine Aufforderung zum An- oder Verkauf von Finanzinstrumenten zu verstehen und sollen auch nicht so verstanden werden. Sie stellen lediglich die persönliche Meinung der Podcastmacher dar. Der Handel mit Finanzprodukten unterliegt einem Risiko. Sie können Ihr eingesetztes Kapital verlieren. Und: Bewertungen bei Apple (oder auch Spotify) machen mir Freude: http://www.audio-cd.at/spotify http://www.audio-cd.at/apple Du möchtest deine Werbung in diesem und vielen anderen Podcasts schalten? Kein Problem!Für deinen Zugang zu zielgerichteter Podcast-Werbung, klicke hier.Audiomarktplatz.de - Geschichten, die bleiben - überall und jederzeit! 3190 full no Christian Drastil Comm. (Agentur für Investor Relations und Podcasts)

En el capítulo 1.139 de este viernes, 19 de junio, @franaldaya les comenta que Morgan Stanley ve a Argentina volviendo al índice de emergentes de MSCI entre fines de 2027 y 2028 mientras la balanza comercial marca un superávit récord de US$3.504 millones. Telecom Argentina se hundió en Nueva York tras conocerse las condiciones para quedarse con Telefónica, y que Wall Street rebotó con el acuerdo Irán-EE.UU. mientras los bonos colombianos volaron de cara al ballotage del domingo 21. Además, Tomás Carrió con Milo Farro, analista de Rava Bursátil, en #ElCierre de la semana.

TKIs are all the rage. But what do the data tell us about their ability to effectively treat wet AMD? Akshay Thomas, MD, outlines findings from DAVIO 2, the phase 2 study assessing the safety and efficacy of EYP-1901 (EyePoint Pharmaceuticals) for the treatment of wet AMD. And Aaron Lee, MD, MSCI, and Cecelia Lee, MD, MS, recap their Cogan Award Lecture from this year's ARVO annual meeting. Hear how they envision a future of ophthalmic research driven by AI and machine learning—and how they know we can only get there by looking back at where we've been.

Unser Partner Scalable Capital ist der einzige Broker, den deine Familie zum Traden braucht. Bei Scalable Capital gibt's nämlich auch Kinderdepots. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Trump droht Iran wieder mit Bomben. Goldman Sachs knackt 1 Bio. $ Dealvolumen. Thoma Bravo verliert 5 Mrd. $. MSC will Hapag-Lloyd?! Ferrari mit E-Auto-Sammlertrick. Snap zeigt AR-Brille für 2.200 $. UniQure springt. Ersten Zinsentscheid von Kevin gab's. Indonesien droht der Abstieg zum Frontier-Markt. MSCI entscheidet nächste Woche. 13 Mrd. $ könnten abfließen. Der Leitindex ist schon 30% gefallen. Was das für Schwellenländer-Investments bedeutet. Visa (WKN: A0NC7B) und Mastercard (WKN: A0F602) sind so günstig bewertet wie lange nicht. Beide setzen auf Stablecoins, aber mit komplett verschiedenen Strategien. Wer gewinnt? Auf Polymarket hat ein Nutzer fast 1 Mio. $ verloren. Diesen Podcast vom 18.06.2026, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung. Learn more about your ad choices. Visit megaphone.fm/adchoices

En el capítulo 1.136 de este martes, 16 de junio, @franaldaya conversa con Javier Timerman, cofundador y managing partner de Adcap Grupo Financiero, sobre la posibilidad de que Argentina vuelva a emitir deuda en los mercados internacionales con el riesgo país en mínimos de ocho años, las perspectivas para un upgrade a mercado emergente de MSCI y la normalización financiera de cara a las elecciones de 2027. Además, qué pasó este lunes en los mercados internacionales.

Americana Partners LLC Market Commentary is a financial podcast for investors, clients, and market-focused listeners who want clear perspective on the economy, investing, and portfolio strategy. Hosted by Melissa Giles and based on the market views and special reports of David M. Darst, Chief Investment Officer at Americana Partners, the show breaks down monthly market commentary, economic conditions, investment strategy, asset allocation themes, and the forces shaping today's financial markets. Each episode is designed to help listeners better understand market trends, long-term investing, and how to think clearly in changing environments. If you are looking for a smart, approachable source for market updates, economic outlook, wealth management insight, portfolio positioning, and investment commentary, subscribe to stay informed with timely perspectives from Americana Partners.   Join Our Distribution List – For a full copy of our report. Americana Partners - https://www.americanapartners.com/contact/  Americana Partners Website - https://www.americanapartners.com/  Linked In - https://www.linkedin.com/company/americana-partners/  Spotify - https://open.spotify.com/show/3rX19ND89pwEob9efsFNNF  iTunes - https://podcasts.apple.com/us/podcast/americana-partners/id1496186853    Disclosures Americana Partners, LLC is registered as an investment adviser with the SEC. The firm only transacts business in states where it is properly registered, or is excluded or exempted from registration requirements. Registration as an investment adviser does not constitute an endorsement of the firm by securities regulators nor does it indicate that the adviser has attained a particular level of skill or ability. A copy of Americana Partners' current written disclosure brochure filed with the SEC which discusses among other things, Americana Partners' business practices, services and fees, is available through the SEC's website at: www.adviserinfo.sec.gov. The tax and legal information contained in this newsletter is general in nature. It should not be construed as legal or tax advice. Always consult an attorney or tax professional regarding your specific legal or tax situation. Foreign securities, foreign currencies, and securities issued by U.S. entities with substantial foreign operations can involve additional risks relating to political, economic, or regulatory conditions in foreign countries. These risks include fluctuations in foreign currencies; withholding or other taxes; trading, settlement, custodial, and other operational risks; and less stringent investor protection and disclosure standards in some foreign markets. All of these factors can make foreign investments, especially those in emerging markets, more volatile and potentially less liquid than U.S. investments. In addition, foreign markets can perform differently from the U.S. market. Investing involves certain risks, including possible loss of principal. You should understand and carefully consider a strategy's objectives, risks, fees, expenses and other information before investing. The views expressed in this commentary are subject to change and are not intended to be a recommendation or investment advice. Such views do not take into account the individual financial circumstances or objectives of any investor that receives them. The strategies described herein may not be suitable for all investors. There is no guarantee that the adviser will meet any of its investment objectives. All indices are unmanaged and are not available for direct investment. Indices do not incur costs including the payment of transaction costs, fees and other expenses. This information should not be considered a solicitation or an offer to provide any service in any jurisdiction where it would be unlawful to do so under the laws of that jurisdiction. Past performance is no guarantee of future results. It is not possible to invest directly in an index. Exposure to an asset class represented by an index is available through investable instruments based on that index. The S&P 500® Index is a widely recognized, unmanaged index of 500 common stocks which are generally representative of the U.S. stock market as a whole. The Nasdaq Composite® Index is the market capitalization-weighted index of over 2,500 common equities listed on the Nasdaq stock exchange. The types of securities in the index include American depositary receipts, common stocks, real estate investment trusts (REITs) and tracking stocks, as well as limited partnership interests. The EAFE® Index is a stock index offered by MSCI that covers non-U.S. and Canadian equity markets. It serves as a performance benchmark for the major international equity markets as represented by 21 major MSCI indices from Europe, Australasia, and the Middle East. The EAFE® Index is the oldest international stock index and is commonly called the MSCI EAFE Index. The Russell 2500® is a market-cap-weighted index that includes the smallest 2,500 companies covered in the broad-based Russell 3000 sphere of United States-based listed equities. All 2,500 of the companies included in the Index cover the small- and mid-cap market capitalizations. The Russell 1000® Growth Index is an unmanaged index that measures the performance of the large-cap growth segment of the U.S. equity universe. It includes those Russell 1000® Index companies with higher price-to-book ratios and higher forecasted growth values. The CBOE Volatility Index (VIX) is a measure of expected price fluctuations in the S&P 500 Index options over the next 30 days. The VIX is calculated in real time by the Chicago Board Options Exchange (CBOE). P/E or Price to Earnings ratio is indicates the dollar amount an investor can expect to invest in a company in order to receive one dollar of that company's earnings. The Consumer Confidence Survey® reflects prevailing business conditions and likely developments for the months ahead. The Manufacturing Business Outlook Survey is a monthly survey of manufacturers in the Third Federal Reserve District; Participants indicate the direction of change in overall business activity and in the various measures of activity at their plants: employment, working hours, new and unfilled orders, shipments, inventories, delivery times, prices paid, and prices received. The ISM manufacturing index, also known as the purchasing managers' index (PMI), is a monthly indicator of U.S. economic activity based on a survey of purchasing managers at more than 300 manufacturing firms. The Composite Index of Leading Indicators, otherwise known as the Leading Economic Index (LEI), is an index published monthly by The Conference Board. It is used to predict the direction of global economic movements in future months. A bond rating is a letter-based credit scoring scheme used to judge the quality and creditworthiness of a bond. The option adjusted spread (OAS) measures the difference in yield between a bond with an embedded option, such as an MBS or callables, with the yield on Treasuries. Mean reversion, in finance, suggests that various phenomena of interest such as asset prices and volatility of returns eventually revert to their long-term average levels. A meme stock is a security that has seen an increase in trading volume after going viral on social media or an online forum. This document may contain forward-looking statements relating to the objectives, opportunities, and the future performance of the U.S. market generally. Forward looking statements may be identified by the use of such words as; “believe,” “expect,”“anticipate,”“should,”“planned,”“estimated,”“potential”and other similar terms. Examples of forward-looking statements include, but are not limited to, estimates with respect to financial condition, results of operations, and success or lack of success of any particular investment strategy. All are subject to various factors, including, but not limited to general and local economic conditions, changing levels of competition within certain industries and markets, changes in interest rates, changes in legislation or regulation, and other economic, competitive, governmental, regulatory and technological factors affecting a portfolio' operations that could cause actual results to differ materially from projected results. Such statements are forward-looking in nature and involve a number of known and unknown risks, uncertainties and other factors, and accordingly, actual results may differ materially from those reflected or contemplated in such forward-looking statements. Prospective investors are cautioned not to place undue reliance on any forward looking statements or examples. This material is proprietary and may not be reproduced, transferred, modified or distributed in any form without prior written permission from Americana Partners. Americana Partners reserves the right, at any time and without notice, to amend, or cease publication of the information contained herein. Certain of the information contained herein has been obtained from third-party sources and has not been independently verified. It is made available on an "as is" basis without warranty. Any strategies or investment programs described in this presentation are provided for educational purposes only and are not necessarily indicative of securities offered for sale or private placement offerings available to any investor. The mention of any individual security should not be construed as a recommendation to buy or sell that security.

This is our weekly market update where we start in the US, cross to Europe and Asia and end in Australia, covering commodities and crypto along the way. It was a positive week, with the US volatility index falling nearly 18% and the MSCI global equities index up1.16% on Friday, while the STOXX 600 in … Continue reading "Markets Moonshot Thanks To SpaceX, AI Bets And The Iran “Deal”"

Chief Asia Economist Chetan Ahya joins Head of India Research and Chief India Equity Strategist Ridham Desai to break down India's macro outlook, capital flows and sector opportunities.Read more insights from Morgan Stanley.----- Transcript -----Chetan Ahya: Welcome to Thoughts on the Market. I'm Chetan Ahya, Morgan Stanley's Chief Asia Economist.Ridham Desai: And I'm Ridham Desai, Morgan Stanley's Head of India Research and Chief India Equity Strategist.Chetan Ahya: Today, the biggest takeaways from our India Investment Forum in Mumbai. From the shifting outlook for India's markets and flows to the sectors driving the next phase of corporate earnings and CapEx.It's Friday, June 12th at 7PM in Hong Kong.Ridham Desai: And 4:30PM in Mumbai.Chetan Ahya: Ridham, the Morgan Stanley's India Investment Forum took place in Mumbai last week, and I was there with you. These events are a great opportunity to speak with investors who come across from the globe to attend. Now that we have had a few days to process the conversations, what stood out to you? What was the biggest shift in investor sentiment that you picked on?Ridham Desai: So, Chetan, I think it's been the case of a continuing story about India. Domestic investors look that they are bullish, and foreign investors continue to stay rather cautious on the Indian markets. We could see that in the overall attendance. In contrast, I think domestic investors were looking for the next stock that they wanted to buy. They were seeking opportunities, and there was a lot of interest in meeting companies.Before we get into markets, let me turn back to you from a macro side. India's growth story remains strong, but relative growth appears to be cooling. This is in contrast to markets like Japan, Taiwan, Korea, and the US. How should investors think about India's macro positioning in that context?Chetan Ahya: So, Ridham, when I look at the macro data in India, they're all indicating a meaningful upside in the growth trend. So I'll just cite two key cyclically sensitive macro data points. One is the banking system credit growth, and number two is the auto sales, particularly the passenger vehicle. So bank credit growth is growing as of the last biweekly data point that we got. It's growing at seventeen point seven percent year-on-year, and car sales are growing at twenty-seven percent in the month of May.But as you were mentioning earlier, the relative growth opportunity is a challenge for India and to just share the numbers on the earnings growth for the first quarter that we saw across the region. So we saw Korea's earnings growth at one hundred and seventy percent. We saw Taiwan's earnings growth at forty-eight percent year on year. Japan at thirty-three percent. The US has seen a growth of about twenty-seven percent year on year.So in that context, when India is reporting thirteen percent growth, it's becoming a challenge for investors to look for opportunities in India relative to other markets. Either they are more focused on the other markets than India. So let me come back to you, Ridham. Staying with the investment implications, India projects stable valuations and strong corporate earnings, but its relative growth advantage has narrowed. How should investors reconcile this contradiction?Ridham Desai: If I go back thirty-five years, as long as we have the MSCI index series, and as far as I have been in this industry, this is the lowest relative multiple that India has traded at. And indeed, growth last year was weak. But if you see QOQ, we have started to accelerate. The broad market earnings growth trajectory has shown a doubling in the quarter that ended March over the quarter that ended December.But it underscores the point you made about the relative growth complex. It's clearly not in India's favor. And a lot of the capital in the world is short-term oriented, and it cares for what growth is gonna come in the next quarter or two. And that's the state of the market right now.However, what I would say is that equities is a quintessential long-duration asset class. In the long run, what matters is terminal growth. I don't really think India's terminal growth has moved much. It remains far superior to a lot of other countries around the world. And therefore, I think this does present itself as a great opportunity for a long-term investor while the markets are digesting this relative growth disadvantage that India seems to have over the next, say, three or four quarters.Chetan Ahya: And Ridham, another theme from the forum was policy action to attract capital. Policymakers announced a number of measures right as our conference ended and they aimed to withdraw withholding tax on debt investors, also providing banks with an incentive to take up more dollar borrowing. How central are these measures to sustaining foreign inflows into Indian markets?Ridham Desai: I think the measures taken by policymakers are very important, probably amongst the most important policy actions this year. The removal of taxation on debt investors will make a difference. The provision for hedging to external commercial borrowings as well as to foreign currency deposits will make a difference.It should boost flows into India over the next twelve months. That said, these measures may not help the equity flows because the equity flows, I think, are going to depend on the relative growth situation. Now, there's only that much India can do to lift its growth. It may accelerate to the high teens. So growth elsewhere needs to decelerate for equity investors to return. Or India needs to see the start of a major IPO cycle because in primary issuances, foreigners do come to buy, and that may change the net picture on FBI flows in the equity markets.But as far as the debt markets are concerned, I think the measures taken last week are going to prove to be quite potent, and India should see the benefits accruing over the next few weeks and months.Chetan, from your perspective, how important is the policy backdrop right now in determining whether India can keep attracting long-term global capital despite more competitive returns elsewhere in the short run?Chetan Ahya: So Ridham, I think the key focus for the policymakers had been with these measures to boost short-term capital inflows to stabilize the currency. There has been a balance of payment deficit. So from that perspective, the short-term capital inflow augmentation effort as you mentioned, has been the correct move. But from the long-term perspective, we think that the government needs to boost competitiveness of the Indian manufacturing. Because in the context in which AI could affect India's services exports, there is a need to augment more export receipts from the manufacturing sector. At the same time, if they improve the competitiveness of the manufacturing sector, it will help India to attract more capital inflows from long-term investors for the purpose of FDI.And the good news is that the government is on it. They are taking a number of measures to boost that competitiveness in the manufacturing. But we think that there is more action needed and hopefully in the intention to improve the balance of payment dynamics and exports from manufacturing sector, we will see more actions from the government in the coming months.Ridham Desai: Chetan, you've also written extensively about the structural capital spending cycle in Asia and India. Can you walk us through the key details here, especially in the Indian context?Chetan Ahya: I think the key story that we are observing, it's sort of more or less global, but definitely very clearly seen in Asia, that there seems to be a super cycle for CapEx as well as industrial activity. This CapEx cycle is effectively driven by spending in four key sectors, and that is AI and AI-related digital infrastructure, energy, defense, and industrial onshoring-related CapEx.Now, as far as India is concerned, we are seeing investments in all the four segments that I just mentioned. In fact, it's seeing a significant amount of activity in the space of energy. And, similarly, we are seeing a lot of policy measures, I mentioned earlier, in terms of boosting manufacturing competitiveness.But at the heart of it is government's effort to onshore industrial supply chain. So India's CapEx has also inflected higher. Having said that, the difference between India and, let's say, North Asia, which is Korea, Taiwan, Japan and China, is that they are also a big player in the export market for capital goods when there is global CapEx cycle upswing happening. Nevertheless, India will see the benefit of this CapEx cycle in terms of its own growth push, as well as improvement in productivity.So Ridham, how would you think about the sectoral opportunity within the Indian markets?Ridham Desai: We see a lot of interest in some of these sectors which you mentioned. But actually, I would like to start off with financials. I see the banks in a very sweet spot. Balance sheets are in pristine condition. The interest rate cycle has troughed, which means margins for the banks have also bottomed and credit growth is finally accelerating. If this CapEx cycle unfolds like the way you are describing it, I think financials will stand to gain the most.And interestingly, the valuations are quite good, both on an absolute as well as on a relative basis. Also, of course, investors can go directly into those sectors which are doing this capital spend. Energy to start with, semiconductors, fertilizers, data centers and aerospace.The only thing to note here is that not everywhere are the valuations attractive enough because in some cases the market has recognized the coming growth cycle and has started to price that in. So we have to be careful about the valuations. But I think financials and industrials are clearly great opportunities in the context of this CapEx recovery that India is likely to see in the coming five years.Chetan Ahya: And additionally, the most requested companies at the summit, Ridham, were consumer sector companies. What do you think investors are looking for at this sector over others?Ridham Desai: So, Chetan, I think from a structural perspective, the Indian consumer is quite clearly the best place to be. In fact, I would say that it's the leverage that India enjoys over the rest of the world.The one point five billion people in this country are split across, say, a hundred and fifty cohorts of ten million each, and each of these cohorts have got different consumption opportunities. So depending on what product or service you're offering to your consumers, there's a market in India, and which in nominal terms is growing between ten and fifteen percent.As we know, last year India accounted for something around seventeen or eighteen percent of global GDP growth, which means depending again on what you are selling to your consumer, India could be between ten and hundred percent of your revenue growth. So India's consumer is something that hardly anybody can avoid.So in summary, Chetan, when I look at it from an investment opportunity, financials, industrials, and consumption, not necessarily in that particular order, are probably the best places for investors to look at. However, IT services, I think could be the dark horse. It's a sector right now which is disrupted or potentially disrupted by AI, and there's a lot of confusion there.But I think as the dust settles on this, it may emerge as one of the most interesting areas for investors to look at. So there's a lot of stuff in India happening right now. I think growth is accelerating. Valuations are looking quite interesting. In fact, the best that they've been in many, many years.Trading performance suggests that investors are not positioned at all. And if things start looking up, then India could be a very good market in the coming twelve months.Chetan Ahya: Ridham, thanks for taking the time to talk.Ridham Desai: Great speaking with you, ChetanChetan Ahya: And thanks for listening. If you enjoy our Thoughts on the Market, please leave us a review wherever you listen and share the podcast with a friend or a colleague today.

In today's episode on 12th June 2026, we explain what India's fall in the MSCI Emerging Markets Index reveals about the benchmark itself.Book a FREE call with Ditto

Interview with Amal Isaiah, MD, PhD, MBA, author of Deep Learning in Otolaryngology: A Narrative Review, and Matthew A. Shew, MD, MSCI, author of Shifting the AI Questions in Otolaryngology From “Can We Build a Model?” to “Will It Improve Patient Care?” Hosted by Paul C. Bryson, MD, MBA. Related Content: Deep Learning in Otolaryngology Shifting the AI Questions in Otolaryngology From “Can We Build a Model?” to “Will It Improve Patient Care?”

Questions? Thoughts? Send a Text to The Optometry Money Podcast! We'll answer your question on the show.Episode SummaryThe largest IPO in history is here. SpaceX goes public this week with an expected total value of $1.77 trillion, and OpenAI and Anthropic have both announced plans to go public this year at valuations around $1 trillion each. In optometry forums and online communities everywhere, ODs are asking the same question: should I get in?In this episode, we look at 45 years of data and research on how IPOs have actually performed for investors - and then dig into the question that matters more for most listeners: how index funds and other passive funds will add these mega IPOs to their portfolios, and what that means for you.Have questions about your own investment approach? Reach out at podcast@optometrywealth.com.What You'll LearnWhat an IPO is and why 2026's IPOs are historic in sizeHow IPOs have historically performed compared to the broad US stock marketWhy the famous "first-day pop" doesn't benefit everyday investorsThe distribution of individual IPO outcomes over 3 and 5 years — and why most lose moneyWhy periods of peak IPO hype tend to be followed by the worst returnsHow the S&P 500, Russell, CRSP, and MSCI indexes decide when (and how much of) an IPO to includeWhat "float adjustment" means and why these trillion-dollar companies will enter index funds as tiny sliversHow the Nasdaq-100's approach to IPOs differs from broad market indexesWhether index fund "front-running" around IPO inclusions should worry long-term investorsHow factor-based funds like Dimensional handle newly public companiesKey Takeaways for OptometristsInvesting in IPOs right after they go public has historically been a poor strategy. IPOs as a group have trailed the broad market, and when you look at individual companies, roughly 60% lost money over their first three to five years - while a small sliver delivered lottery-like gains that lift the averages. Betting on IPOs means betting you can pick those rare winners.For index fund investors, these mega IPOs will eventually show up in your funds - but because indexes are float-adjusted, even a $1.77 trillion company may enter as a fraction of a percent of the index. The impact on your portfolio, good or bad, is small.The bigger lesson: when hype is at its highest, expected returns tend to be at their lowest. Staying broadly diversified, keeping costs low, and not chasing shiny objects continues to be the prudent approach - and if you do want a lottery ticket, be honest about what it is and size it accordingly.Related Episodes:Ep 134: The Case for Index Funds – Why Optometrists Should Embrace Passive InvestingEp 135: Beyond Indexing – An Optometrist's Guide to Factor-Based InvestingEp 58: Investing Fundamentals – Understanding Stocks, Bonds, Mutual Funds, and ETFsEp 153: How to Invest Tax-Efficiently and Keep More of Your Returns (After-tax)Resources for OptometristsLoughran & Ritter (1995), "The New Issues Puzzle" — Journal of FinanceDimensional Fund Advisors (2019), "What to Know About IPOs" research studyDimensional Fund Advisors 2025 video: Do IPOs Have a Place in Your Portfolio?Jay Ritter's Long-Run Returns on IPOs (University of Florida)2025: Primary Capital Market Transactions and Index FundsCullen Roche's Article: Three Things – 100s, SpaceX, & IndexingWant a more proactive approach to your planning?You can schedule a no-commitment introductory call to discuss what's on your mind financially and learn how we help optometrists navigate those same decisions nationwide.

Interview with Amal Isaiah, MD, PhD, MBA, author of Deep Learning in Otolaryngology: A Narrative Review, and Matthew A. Shew, MD, MSCI, author of Shifting the AI Questions in Otolaryngology From "Can We Build a Model?" to "Will It Improve Patient Care?" Hosted by Paul C. Bryson, MD, MBA. Related Content: Deep Learning in Otolaryngology Shifting the AI Questions in Otolaryngology From "Can We Build a Model?" to "Will It Improve Patient Care?"

1:45 緩漲急跌是市場慣性。沒有利空下，基本是多方控盤 3:20 資金市場平平，股市吸血加密貨幣 4:40 貨幣政策緊縮，SOFR、FED官員談話 8:27 潛在利空之二: AI買家外部融資訊息，美伊影響已經有限 10:05 開高對台股輪動不利，控盤指數的資金注意力集中 14:28 時序上: 月底有富台月結算、MSCI調整 股票期貨是熱門、好用、彈性的工具 15:55 優點一: 面對現股處置，股期有流動性 20:20 優點二: 期交所修法，針對千金股tick改1元，7/6上路! 24:56 優點三: 投信重倉股破線多殺多，用股期以短線反彈稍微回血 -- Hosting provided by SoundOn

The 10-year Treasury rising past 4.5% has taken the wind out of real estate's recovery sails. Momentum gained in Q1 is already reversing as the war in Iran pushes on inflation. MSCI Chief Economist of Real Estate Research Jim Costello said the volatile bond market is “a new wrench thrown into the works.” And while he believes the CRE recovery is still underway, it's tenuous.“[Investors] need to do more scenario planning these days, because that's how you can deal with the growing uncertainty in the market,” he said.

On this episode of Chit Chat Stocks, we go through another Ryan Research Episode covering MSCI Inc. We discuss:(00:00) Introduction(03:15) The Importance of Indexes and Benchmarking(06:12) Challenges in Building and Maintaining Indexes(09:25) Revenue Generation and Business Model of MSCI(12:19) The Role of AI in Index Management(15:22) Future Growth and Market Trends for MSCI(31:33) The Role of MSCI in the ETF Market(33:43) Growth Potential and Market Trends(35:01) Competitive Advantages of MSCI(40:44) Comparing Moats: Stock Exchanges vs. Index Providers(45:50) Valuation Insights and Future Projections(51:52) Investment Decisions and Market Considerations*****************************************************Subscribe to our newsletter, Emerging Moats: emergingmoats.com *********************************************************************Chit Chat Stocks is presented by Interactive Brokers. Get professional pricing, global access, and premier technology with the best brokerage for investors today: https://www.interactivebrokers.com/ Interactive Brokers is a member of SIPC. *********************************************************************Check out Value Spotlight: Stockwriteup.com *********************************************************************Fiscal.ai is building the future of financial data.With custom charts, AI-generated research reports, and endless analytical tools, you can get up to speed on any stock around the globe. All for a reasonable price. Use our LINK and get 15% off any premium plan: ⁠https://fiscal.ai/chitchat *********************************************************************Disclosure: Chit Chat Stocks hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation.

Tobias Kramer begrüßt erstmals Torsten Tiedt, Gründer vom Aktienfinder, bei echtgeld.tv und im Format "7+3" – sieben Fragen zur Person, drei Top-Aktien nach seiner Wahl. Im ersten Teil stellt sich Torsten Tiedt persönlich vor, spricht über seine erste Aktie, seinen langfristigen Investment-Ansatz und seine jüngsten Käufe rund um Hyperscaler und den Hardware-Superzyklus. Anschließend diskutieren beide zwei der drei mitgebrachten Aktien ausführlich – die dritte folgt am Dienstag in Teil 2. Darum geht es in der Folge: • Warum MSCI als Index-Anbieter vom Megatrend ETFs profitiert und trotzdem nicht automatisch ein Kauf ist. • Warum Wolters Kluwer als „KI-Verlierer“ abgestraft wird und genau dieses Urteil zu kurz greift. • Warum Torsten bei Qualitätsaktien auf Gewinnwachstum, Dividenden und wiederkehrende Umsätze achtet. • Warum Tobias bei einer Aktie klar bremst und bei der anderen deutlich offensiver wird. • Warum diese Folge zeigt, dass Anleger Qualität und Bewertung sauber trennen müssen. Unterm Strich geht es um eine der härtesten Fragen für langfristige Investoren: Wann verdient ein starkes Unternehmen einen hohen Preis – und wann übertreibt der Markt aus Angst nach unten?

This discussion reviews the late-breaking HRS 2026 study Total Fatal Adverse Events Following Atrial Fibrillation Ablation Reported in an FDA Mandatory Reporting System: A Matter of Concern? The TiFFANY Study, which examined fatal adverse event reports associated with atrial fibrillation ablation using data from the FDA MAUDE database. Faculty discuss the incidence and mechanisms of rare but serious complications across ablation technologies, including pulsed field ablation and thermal energy sources, and explore the implications for procedural safety, post-market surveillance, and clinical decision-making in AF ablation. Join host Melissa E. Middeldorp, MPH, PhD and her esteemed guests Christopher F. Liu, MD, FHRS and James Freeman, MD, MPH, Msci for this late-breaking coverage from Heart Rhythm 2026 in Chicago! Learning Objectives Describe the methodology and key findings of the TiFFANY study evaluating fatal adverse events following atrial fibrillation ablation. Compare reported safety signals and complication profiles among pulsed field ablation and traditional thermal ablation technologies. Assess the role and limitations of post-market adverse event databases in evaluating procedural safety and informing electrophysiology practice.  Podcast Contributors Melissa E. Middeldorp, MPH, PhD, FHRS Christopher F. Liu, MD, FHRS James Freeman, MD, MPH, Msci  Host and Contributor Disclosure(s): D.C. Raja Nothing to disclose. A. Deshmukh Honoraria/Speaking/Teaching/Consulting: GE Healthcare, Biotronik, Medtronic, Biosense Webster Research: AltaThera Pharmaceuticals P. Lim Nothing to disclose.  

Breast Cancer Briefing, hosted by Sara Nunnery, MD, MSCI, a breast medical oncologist and the director of Breast Cancer Research at Tennessee Oncology in Nashville, is a podcast series that breaks down the latest news in breast cancer research, one conversation at a time.In this episode, Nunnery sat down with Annie Bond, a breast cancer survivor and patient advocate.Diagnosed with breast cancer at age 26, Bond shared how her initial concerns about a breast lump were repeatedly dismissed by medical professionals who cited her youth and lack of a family history of breast cancer. It took months of persistence before she received a diagnosis, at which point the cancer had already spread to her liver.Bond emphasizes the necessity of self-advocacy and the value of seeking second or third medical opinions. Regarding fertility preservation, her first oncologist discouraged her from freezing her eggs, but her third oncologist provided a more personalized approach, using CDK4/6 inhibitors rather than immediate chemotherapy based on her luminal A disease subtype.A significant portion of the conversation focused on the mental health toll of cancer. Bond discusses the "warrior" stereotype, the guilt and shame she felt, and her struggle with post-traumatic stress disorder. She says she found critical support in community and support groups, which helped normalize her feelings and provided a sense of belonging.Regarding physical adverse effects, Bond detailed the challenges of medical menopause, including "menopause brain" and joint pain, which she manages through walking and stretching. She expressed frustration with health education that focuses on diet or alcohol as "blame" factors, noting that cancer can often develop regardless of lifestyle.Bond explained how she advocates for metastatic breast cancer research funding and the use of artificial intelligence risk assessment models to account for factors like breast density. Her mission is to increase early detection and ensure patients with metastatic disease are viewed with hope.

Jessica Inskip walks us through today's Big 3 trades. She likes Arch Capital (ACGL) as a top tier stock in its sector, Comfort Systems (FIX) as they're becoming increasingly tied to AI infrastructure demand, and MSCI (MSCI) as it highlights record reoccurring subscriptions. Rick Ducat takes us through the key support and resistance levels to watch in the stock charts.======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Breast Cancer Briefing, hosted by Sara Nunnery, MD, MSCI, a breast medical oncologist and the director of Breast Cancer Research at Tennessee Oncology in Nashville, is a podcast series that breaks down the latest news in breast cancer research, one conversation at a time.In part 2 of this conversation, filmed live onsite at the 43rd Annual Miami Breast Cancer Conference, Dr Nunnery sat down with Irene Morae Kang, MD, an assistant professor in the Department of Medical Oncology & Therapeutics Research and the medical director of Women's Health Medical Oncology at City of Hope Orange County in Irvine, California.Their discussion focuses on the rapidly evolving treatment paradigm for first-line metastatic triple-negative breast cancer (TNBC), including the emergence of new data that is shifting standards of care. Dr Kang explained that TNBC is defined by the absence of estrogen, progesterone, and HER2 receptors, which historically restricted treatment options to non-targeted chemotherapy. A primary focus of the conversation was the role of PD-L1 expression and the use of immunotherapy. Dr Kang described PD-L1 as a checkpoint inhibitor protein on cancer cells that shuts off the immune system. By blocking this protein, oncologists can keep the body's T-cells vigilant to fight the cancer. However, she noted that immunotherapy is typically reserved for the approximately 40% of patients who express PD-L1 and may be contraindicated for those with active autoimmune diseases or a history of severe immune-related toxicities.The dialogue transitioned into the use of antibody-drug conjugates (ADCs). Dr Kang reviewed data from major trials using TROP2-targeting ADCs in the first-line setting. Dr Kang emphasized the importance of using these highly effective agents early, as many patients with TNBC do not survive to receive a second line of therapy.Finally, Dr Kang highlighted the distinct toxicity profiles and administration schedules that guide clinical decision-making. Although sacituzumab govitecan-hziy (Trodelvy) is frequently associated with neutropenia and alopecia, the primary toxicities associated with datopotamab deruxtecan-dlnk (Dato-DXd; Datroway) are stomatitis and ocular adverse effects like dry eye. Using Dato-DXd in practice requires a rigorous prophylactic regimen, including steroid mouthwash and lubricating eye drops. Ultimately, Dr Kang noted that because efficacy appears similar between the 2 ADCs, the choice often rests on the patient's lifestyle, their ability to adhere to preventative AE protocols, and infusion schedule preference.

Is it time to look past the U.S. tech concentration? For many traders, "the market" has become synonymous with a handful of domestic tech names. But with 40% of the world's investable equity sitting outside the U.S., ignoring the international tape means missing out on massive shifts in financials, defense, and emerging tech hubs. In this episode, Mark Longo sits down with a panel of experts to discuss how to navigate the global landscape using the MSCI ecosystem. We explore why the "only free lunch in finance" is back in style and how the pros are using listed derivatives to manage risk across different time zones and regimes. On the Hot Seat: Ratchna Mathur, Executive Director, Eurex Anshul Kamra, Head of Index Derivatives and Systematic Strategies Research, MSCI Inc. Vas Koutsoulis, Index Derivatives Product (EMEA), MSCI Inc. Discussion Highlights: The Concentration Crisis: Why the U.S. market's top-heavy nature is driving a hunt for global alternatives. The Global Semi Play: Accessing the AI infrastructure boom through Taiwan and Korea. Regional Deep Dives: From the resilient European financials to the shifting energy correlations in the GCC. Operational Edge: How to use Eurex's 21-hour trading window to eliminate overnight gap risk. For more on global benchmark trading, visit www.eurex.com .

Breast Cancer Briefing, hosted by Sara Nunnery, MD, MSCI, a breast medical oncologist and the director of Breast Cancer Research at Tennessee Oncology in Nashville, is a podcast series that breaks down the latest news in breast cancer research, one conversation at a time.In part 2 of this conversation, filmed live onsite at the 43rd Annual Miami Breast Cancer Conference, Dr Nunnery sat down with Neil M. Iyengar, MD, an associate professor and co-director of Breast Medical Oncology in the Department of Hematology and Medical Oncology at the Emory University School of Medicine, as well as the director of Survivorship Services at the Winship Cancer Institute of Emory University in Atlanta, Georgia.Their conversation highlighted the evolving integration of GLP-1 agonists into the breast cancer treatment armamentarium.

 On February 28, the Strait of Hormuz shut down, stranding 20% of the world's crude exports and 20% of global LNG capacity. Energy crises usually send the world running back to coal; but this time, coal generation outside China actually fell, while wind, solar, and batteries picked up the slack. Host Mike Disabato talks with MSCI's Chris Cote about whether a war in the Middle East just accelerated the end of fossil fuels, which industries can pivot now, and why countries burned twice by energy dependence may never go back. Episode reading: The Opportunity in Energy Disruption — Batteries IncludedHost: Mike Disabato, MSCI Sustainability & ClimateGuest: Chris Cote, MSCI Sustainability & Climate

In this podcast, experts Kevin Kalinsky, MD, MS; Adam Brufsky, MD, PhD; Kelly Elizabeth McCann, MD, PhD; and Sara Nunnery, MD, MSCI, review pivotal clinical trials investigating novel endocrine therapies and targeted combination regimens for hormone receptor-positive, HER2-negative metastatic breast cancer, and discuss strategies for selecting the optimal treatment approach for individual patients.

On a recent visit to Sydney, MSCI's global head of sustainability and climate index Sebastien Lieblich sat down with The Greener Way to shed light on how institutional investors, particularly superannuation funds, are changing their approach to climate investing.Gone are the days of simply excluding or divesting companies, he says. Asset owners are looking more closely at the role benchmarks and index design can play in implementing their goals, embedding climate considerations in investment strategies.Lieblich also touches on the potential ramifications of the current geopolitical environment and how a disruption to traditional energy sources and supplies could impact the global transition.We record on Gadigal land and we pay our respects to the traditional custodians of country and elders past and present.https://www.fssustainability.com.au/This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

The recent sell-off in software has sparked a broader reassessment of risk across private credit. But are managers pulling back from risk, or just recalibrating how they price it?In this episode of Cloud 9fin, private credit reporter Anna Russi sits down with Patrick Warren, head of private credit research at MSCI, to unpack what's driving the shift. Drawing on new data, they explore where signs of stress are emerging in software lending and venture debt, how valuation marks could be masking underlying pressures, and what this reveals about risk, performance, and portfolio assumptions in today's market.Have any feedback for us? Send a note to podcast@9fin.com.

Breast Cancer Briefing, hosted by Sara Nunnery, MD, MSCI, a breast medical oncologist and the director of Breast Cancer Research at Tennessee Oncology in Nashville, is a podcast series that breaks down the latest news in breast cancer research, one conversation at a time.In today's episode, filmed live onsite at the 43rd Annual Miami Breast Cancer Conference, Dr Nunnery sat down with Neil M. Iyengar, MD, an associate professor and co-director of Breast Medical Oncology in the Department of Hematology and Medical Oncology at the Emory University School of Medicine, as well as the director of Survivorship Services at the Winship Cancer Institute of Emory University in Atlanta, Georgia.Their conversation centered around lifestyle and medical interventions pertinent to breast cancer survivorship. Dr Iyengar explained that although endocrine therapies can be life-saving, they disrupt estrogen signaling, which can lead to cardiometabolic dysfunction, including increased risks for diabetes, heart disease, and bone health issues. He noted that weight gain associated with these treatments is often tied to the induction of a post-menopausal state, which disrupts energy homeostasis and promotes inflammation.A key theme of the conversation was Dr Iyengar's explanation of a "drug development paradigm" for lifestyle changes. Rather than offering generic advice, his research focuses on precision lifestyle interventions, treating diet and exercise as prescribed medical therapies with specific "doses". He highlighted that body mass index (BMI) is an insufficient tool for risk stratification, as high body fat despite a normal BMI is a significant risk factor for cancer recurrence.The discussion also covered the rising use of GLP-1 receptor agonists to manage metabolic health. These drugs replicate natural hormones to maintain glycemic balance and reduce hunger. Dr Iyengar addressed the black box warning for thyroid cancer associated with this class of drugs, noting that although the data are mixed, the protective benefits against obesity-related cancers appear to outweigh the risks. Finally, he emphasized that exercise is a critical tool for managing treatment adverse effects like fatigue, noting that although starting is difficult, the "return on investment" for patient health is immense.

Breast Cancer Briefing, hosted by Sara Nunnery, MD, MSCI, a breast medical oncologist and the director of Breast Cancer Research at Tennessee Oncology in Nashville, is a podcast series that breaks down the latest news in breast cancer research, one conversation at a time.In today's episode, filmed live onsite at the 43rd Annual Miami Breast Cancer Conference, Dr Nunnery sat down with Kelly E. McCann, MD, PhD, a breast medical oncologist in the University of California system.Their conversation centered around the evolving HER2-positive breast cancer treatment paradigm. The experts highlighted that although this disease was once associated with a poor prognosis, targeted therapies like trastuzumab (Herceptin) have revolutionized management, making these cancers highly curable.They noted the role of fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu), an antibody-drug conjugate (ADC) that delivers chemotherapy directly to cancer cells and uses a bystander effect to kill neighboring malignant cells. The phase 3 DESTINY-Breast11 trial (NCT05113251) evaluated T-DXd in the neoadjuvant setting for patients with high-risk, HER2-positive early breast cancer. Results showed significantly higher pathological complete response rates with T-DXd followed by docetaxel, trastuzumab, and pertuzumab (Perjeta) compared with standard chemotherapy. Responses were even more pronounced in patients with hormone receptor–negative disease.Furthermore, they spotlighted the phase 3 DESTINY-Breast05 trial (NCT04622319), which examined T-DXd as adjuvant therapy for high-risk patients with residual HER2-positive disease. In this study, T-DXd generated an improvement in invasive disease–free survival compared with standard ado-trastuzumab emtansine (Kadcyla). They noted that a significant benefit of T-DXd is its ability to cross the blood-brain barrier, offering the potential for preventing brain metastases. However, the experts expressed caution regarding interstitial lung disease, a potentially fatal adverse effect associated with T-DXd. Because of this risk, patients who receive T-DXd require frequent, expensive CT monitoring, which Nunnery and McCann explained can pose logistical and insurance challenges in standard practice.Although adjuvant T-DXd has been added to the National Comprehensive Cancer Network Clinical Practice Guidelines for HER2-positive breast cancer, the neoadjuvant regimen has not yet been included, likely awaiting more mature survival data. Both oncologists conclude that although ADC-associated toxicities require vigilant management, these treatment advancements provide powerful new tools for potentially curing high-risk patients with HER2-positive breast cancer.

The Madness continues! This week on Rule Breaker Investing, the second semifinal of March Market Cap Madness tips off as defending world champion Emily Flippen faces long-time Motley Fool advisor Bill Barker for a place in the championship round. It is a rematch of the epic Final Four game they played this very week one year ago. As always, the real game is for you: ten companies, ten market-cap ranges, and one simple question each round: Inside or outside? Play along and keep score as you listen—and see if your intuition can meet or beat our two veteran Foolish analysts. Companies mentioned: ABNB, ACM, ADYEY, GRAB, MIELY, MSCI, PAYC, SKYT, TDG, WIX Host: David GardnerContestants: Bill Barker, Emily FlippenProducer: Bart Shannon Learn more about your ad choices. Visit megaphone.fm/adchoices

Colin and Charlie break down the latest Bitcoin news, from the massive $16k price drawdown and capitulation theories to Bitdeer's legal woes in Ohio and IREN joining the MSCI index. Plus, a deep dive into "quantum resistance" and the historic shift in mining difficulty. Colin and Charlie join us to talk about a wild week in Bitcoin. We dive into the $16,000 price "puke" and whether we've hit a local bottom, explore Bitdeer's legal snag at their Ohio AI flagship site, and discuss IREN's inclusion in the MSCI USA index. We also break down the historic six-out-of-seven negative difficulty adjustments—the first since 2011—and tackle the "ontology of time" and quantum resistance. Subscribe to the newsletter! https://newsletter.blockspacemedia.com Notes: * Bitcoin lost $16,000 within 12 hours last week. * BTC saw a historic 21% daily price drawdown. * Bitdeer's Ohio site has 570MW allocated. * 6 of last 7 difficulty adjustments were negative. * IREN to join MSCI USA index on March 2nd. * Bitcoin hash price recovered to roughly $35/PH. Timestamps: 00:00 Start 04:01 BTC number go down! 10:10 Difficulty Update by Luxor 12:32 Bitdeer lawsuit 18:39 Cleanspark Ad 19:08 IREN added to MSCI USA Index 22:33 The MARA-Exaion plot thickens 29:14 BIP 360 merged 37:49 OP_NEXT Ad 39:21 Cry corner: No one understands anything about anything -

Global markets are leaning into growth. Following the upside surprise in U.S. non-farm payrolls — with 130,000 jobs added and unemployment falling to 4.3% — investors are focusing on economic resilience rather than fading hopes of aggressive rate cuts. MSCI's All-World index is trading near record highs, while South Korea's Kospi has crossed 5,500 for the first time. Attention now turns to initial jobless claims and the upcoming CPI print, which could shape expectations for the Federal Reserve's June decision. CME FedWatch odds for a rate hold have climbed to 40%. In the UK, GDP expanded just 0.1% in Q4, while industrial production fell unexpectedly. Meanwhile, Nuveen has agreed to acquire asset manager Schroders for $13.5 billion. In digital assets, crypto markets remain steady despite Blockfills halting withdrawals. BlackRock is deepening its move into tokenized finance, bringing its Treasury-backed BUIDL token to Uniswap through Securitize. Court drama surrounding FTX has resurfaced, and Kraken has replaced its CFO ahead of its public listing. A busy macro backdrop with institutional crypto developments accelerating beneath the surface.